Consortia are enabling drug discovery in areas that individual organizations are unable to support alone because of the high risk or the need to pool information.
Medicines Discovery Catapult, Retrogenix and Peak Proteins collaborate to identify target receptors for COVID-19.
Sites in Milton Keynes, Glasgow and Alderley Park in Cheshire are now live and are already testing thousands of patient samples for coronavirus (COVID-19) each day.
The second mega-lab at Alderley Park in Cheshire has begun to test thousands of patient samples a day for coronavirus.
The Hearing Medicines Discovery Syndicate and Boehringer Ingelheim today announced a Boehringer Ingelheim Office Hours dedicated to Hearing Loss.
To celebrate British Science Week, Medicines Discovery Catapult have brought their most experienced scientists together with their newest scientists to talk about their motivations to get into drug discovery, as well as the future of the field.
Medicines Discovery Catapult (MDC) have welcomed a cohort of MRC-funded PhD students as part of a training, talent and skills agenda to help develop the next generation of drug discovery researchers.
To mark International Day of Women and Girls in Science, we are celebrating by highlighting some of the MDC women who play a vital part in making drug discovery happen.
The February special issue of SLAS Discovery, ‘Advances in Cellular Target Engagement and Target Deconvolution,’ features 11 articles focused on multiple aspects and technologies of cellular target engagement.
Medicines Discovery Catapult, alongside Incisive Health and use MY data published ‘The Issue with Tissue’…
See how we can help support you with your next drug discovery project.
Speak to us